Reversed-phase high-performance liquid chromatographic determination of the new antitumor agent cyclopentenyl cytosine in biological fluids.

[1]  S. Rutan,et al.  Wetting of octadecylsilylated silica in methanol-water eluents. , 1996, Analytical chemistry.

[2]  J. Plowman,et al.  Reversal by cytidine of cyclopentenyl cytosine-induced toxicity in mice without compromise of antitumor activity. , 1995, Biochemical pharmacology.

[3]  T. Ryan.  HPLC Method Transfer to Narrow Bore Columns: An Evaluation , 1995 .

[4]  George W. A. Milne,et al.  Comparative Molecular Field Analysis of Hydrophobicity Descriptors of Cytosine Nucleosides , 1995 .

[5]  V. Marquez,et al.  The design and synthesis of a new anticancer drug based on a natural product lead compound: From neplanocin a to cyclopentenyl cytosine (cpe‐c) , 1994, Stem cells.

[6]  K. Schram,et al.  Urinary excretion of modified nucleosides as biological marker of RNA turnover in patients with cancer and AIDS. , 1993, Clinica chimica acta; international journal of clinical chemistry.

[7]  V. Marquez,et al.  The Controlled Stereospecific Reduction of Cyclopentenyl Cytosine (CPE-C) to Carbodine and Isocarbodine , 1992 .

[8]  K. Kuo,et al.  Ribonucleoside analysis by reversed-phase high-performance liquid chromatography. , 1989, Journal of chromatography.

[9]  M. A. Priest,et al.  Cyclopentenylcytosine. A carbocyclic nucleoside with antitumor and antiviral properties. , 1988, Journal of medicinal chemistry.

[10]  M. Cohen,et al.  Induction of differentiation in the human promyelocytic leukemia cell line HL-60 by the cyclopentenyl analogue of cytidine. , 1986, Biochemical pharmacology.

[11]  R. I. Glazer,et al.  Cyclopentenyl cytidine analogue. An inhibitor of cytidine triphosphate synthesis in human colon carcinoma cells. , 1985, Biochemical pharmacology.

[12]  M. Ohno.  Enantioselective Synthesis of Carbocyclic Nucleosides by Enzymatic Approach and the Anticancer Activities , 1985 .

[13]  V. Marquez,et al.  Cyclopentenyluridine and cyclopentenylcytidine analogues as inhibitors of uridine-cytidine kinase. , 1984, Journal of medicinal chemistry.

[14]  Lawrence H. Keith,et al.  Principles of environmental analysis , 1983 .

[15]  H. Schmidt,et al.  Properties and diversity of C18 bonded phases , 1982 .

[16]  G D Knott,et al.  Mlab--a mathematical modeling tool. , 1979, Computer programs in biomedicine.

[17]  D. Baumann.  [New drugs. 9]. , 1973, Pharmazeutische Praxis.

[18]  R. Shapiro,et al.  SYNTHESIS OF PSEUDOURIDINE , 1961 .